• What Big Data Means for Pay-for-Performance

    Aug 22, 2013, 12:00 by Michael Croft
    InformationWeek | Some doctors are concerned about big data in their practices. The topic of a recent Wall Street Journal article, some clinicians fear that big data will mean metrics to meet.
    Full story
  • Chemoresponse Assays Help Clinicians Determine Treatment

    Aug 22, 2013, 07:00 by Michael Croft
    OncLive | Researchers evaluated the effectiveness of the ChemoFx assay by testing patients’ tumor samples for sensitivity and resistance to various chemotherapeutic agents.
    Full story
  • Greenphire Fuels Compliance With the Sunshine Act

    Aug 20, 2013, 15:00 by Michael Croft
    Clinical Informatics News | The life sciences sector has taken a giant step toward transparency with the August 1, 2013 launch of the Physician Payments Sunshine Act. But now physicians and hospitals must learn to comply.
    Full story
  • Patient Recruitment Tool Targets Physicians

    Aug 20, 2013, 14:00 by Michael Croft
    PharmaTimes | MD On-Line (MDOL) has released a new patient recruitment tool. ID Recruit is designed to help doctors and the pharmaceutical industry identify the best candidates for clinical trials.
    Full story
  • Competing Drug Companies May Combine Late-Stage Trials of Drug Candidates

    Aug 20, 2013, 14:00 by Michael Croft
    Boston Business Journal | TranCelerate Biopharma reports that it has signed agreements facilitating head to head drug trials. The agreements allow drug makers to buy a competitor’s product for use in comparative clinical trials.
    Full story
  • Quintiles Acquires Novella

    Aug 15, 2013, 14:00 by Michael Croft
    News and Observer | Quintiles has acquired Novella Clinical of Morrisville, North Carolina. Novella is a CRO focusing on supporting companies developing cancer treatments.
    Full story
  • Clinical Trial App Partners with CenterWatch

    Aug 14, 2013, 11:00 by Michael Croft
    Clinical Informatics News | Study Scavenger and CenterWatch are partnering to provide sponsors, contract research organizations (CROs), research centers and patients a mobile solution to their clinical trial needs.
    Full story
  • 82% of Clinicians to be 'Digital Omnivores' Next Year

    Aug 12, 2013, 11:00 by Michael Croft
    MobiHealthNews | According to a survey conducted by athenahealth subsidiary Epocrates, almost 50% of all clinicians in the US are using smartphones, tablets, and desktops—all three of these devices—in professional capacities throughout their workday.
    Full story
  • Updates to FDAs Clinical Trial Imaging Standards

    Aug 12, 2013, 11:00 by Michael Croft
    Bioclinica Blog | In 2011, the FDA issued a guidance entitled 'Standards for Clinical Trial Imaging Endpoints,' designed to aid sponsors in the use of imaging endpoints in clinical trials.
    Full story
  • The Thirteen Year Trial Results Delay

    Aug 6, 2013, 11:00 by Michael Croft
    Forbes | A 13-year delay in trial results publication has garnered criticism. The PRAISE-2 trial was a cardiac trial following up on a surprising finding from the 1995 PRAISE trial, which had results published in 1996 in the New England Journal of Medicine. The follow-up trial was completed in 2000, but the results were neutral. They were just published in JACC: Heart Failure.
    Full story
  • JAMA Waives Academic Review of Industry-Sponsored Trials

    Aug 6, 2013, 10:00 by Michael Croft
    American Medical News | The Journal of the American Medical Association has ended its policy of requiring clinical trials sponsored by industry to be reviewed by outside experts.
    Full story
  • Clinical Trials as a Favor to the Patient

    Aug 2, 2013, 11:00 by Michael Croft
    DiabetesHealth | DiabetesHealth contributing editor talks about his experience as a clinical trial participant. "These people are doing me a favor, so a little pain or discomfort is fair trade."
    Full story
  • Eric Topol on Genomics of Genius, Alzheimer's, Future Hospitals

    Jul 31, 2013, 15:00 by Michael Croft
    Medspace | Eric Topol weighs in on what he's seen interesting on the Web lately including the genomics of genius, Alzheimer's Disease, and the obsolete future of the hospital room.
    Full story
  • The New House Call

    Jul 30, 2013, 12:00 by Michael Croft
    Boston Globe | Doctors may not make house calls anymore, but your in-home health monitoring devices--scales, blood pressure cuffs, glucometeres, etc.--could send data directly your electronic record so your physician can track your progress. The system launched last month in Boston at Partner's HealthCare.
    Full story
  • Risk-Based Monitoring’s Potential to Reduce Costs, Save Time and Alleviate Monitor Burnout

    Jul 30, 2013, 09:00 by Michael Croft
    Clinical Informatics News | A risk-based approach to clinical monitoring, with multidisciplinary teamwork to design studies and centralized monitoring, can greatly reduce costs, produce better data, accelerate study timeframes and reduce stress for on-site monitors—improving the way the entire industry conducts clinical research
    Full story
  • Halamka on Google Glass, Health IT

    Jul 29, 2013, 14:00 by Michael Croft
    Health Care Blog | John Halamka tries Google Glass and explores ways the technology could be used for health IT--meaningful use II, clinical documentation, decision support, and more.
    Full story
  • Industry and Academia On Open Clinical Trials

    Jul 29, 2013, 14:00 by Michael Croft
    Chronicle of Higher Education | There's a growing trend of openness in clinical trials--led by industry. While government organizations have pushed for trial registration and data sharing, Glaxo, Medtronic, and others are actively opening their data stores to the public.
    Full story
  • Trials on Trial: Do Clinical Trials Really Work?

    Jul 16, 2013, 11:00 by Michael Croft
    New York Times | Do clinical trials even work? Clifton Leaf raises the question about are large trial showed Avastin ineffective against brain cancer. On the one hand, the randomized, controlled trial was based on science, not guesses. But on the other hand, it left researchers no more informed about how to treat brain cancer and why some patients do, apparently, respond.
    Full story
  • TrialShare Brings Much Needed Transparency to Clinical Trials Data

    Jul 15, 2013, 12:00 by Michael Croft
    Clinical Informatics News | Making sense of the millions of data points that characterize a clinical trials database is a tough challenge for sponsors in pursuit of new therapies. For therapeutic areas such as autoimmune disease, allergy and asthma, and transplantation, the Immune Tolerance Network (ITN), an international clinical research consortium, can help. Through TrialShare, a simple-to-use clinical trials research web portal developed at ITN, investigators and study management teams can better interpret data throughout the clinical trials process.
    Full story
  • Misconduct in Chinese Trials, Outcomes for BMS, Pfizer

    Jul 12, 2013, 09:00 by Michael Croft
    In the Pipeline | Bloomberg is reporting that a Bristol-Myers Squibb and Pfizer product approved last year was slowed by misconduct in its Chinese clinical trials.
    Full story